Amjevita
First Biosimilar to Humira Launches
Adalimumab-atto, an anti-tumor necrosis factor (TNF)-alpha monoclonal antibody, was the first biosimilar to Humira ...
FEBRUARY 13, 2023
FDA Approves Amjevita, a Biosimilar to Humira
The anti-inflammatory drug is the fourth biosimilar to be approved in the United States.
SEPTEMBER 29, 2016
Load more